Our team has extensive knowledge and experience in the Biotechnology field, with strong academic and industrial background in microorganisms and mammalian cells use to produce molecules of commercial interest. We have participated in the first projects of biosimilar monoclonal antibodies for human therapeutic use in Brazil, involving Brazilian companies and international partners, as well as in the marketing approval of the first product of this category by a Brazilian company.We can assist your company in a tailored way, according to your needs, and based on our expertise acquired over the last 26 years in several aspects related to the development, production, investment and acquisition of innovative biological products or biosimilars, with a focus on meeting regulatory requirements for the approval of these products.